Aisf 2021 Virtual Meeting
A.I.S.F. - ITA FEBRUARY 22nd | MARCH 3rd‐4th‐5th , 2021
2021-03-03 14:25:00
Downloads
Iscriviti
  • Annual Meeting
  • Home
  • webcasts
    • 22ND AISF VIRTUAL PRE‐MEETING COURSE
    • 53rd AISF Virtual Annual Meeting
  • POSTERS
  • Contacts
  • ACKNOWLEDGMENTS
  • Home
  • webcasts
    • 22ND AISF VIRTUAL PRE‐MEETING COURSE
    • 53rd AISF Virtual Annual Meeting
  • POSTERS
  • Contacts
  • ACKNOWLEDGMENTS
program

posters

N 1 - 30
N.1
Poster
Tenofovir Alafenamide improves proximal tubular markers in CHB patients long‐term treated with Tenofovir Disoproxil Fumarate: a real‐life study based on the EASL switching criteria

A. Loglio, M. Viganò, M. Borghi, C. Gentile, F. Facchetti, D. Sambarino, R. Perbellini, R. Soffredini, S.C. Uceda Renteria, M.G. Rumi, P. Lampertico – Milan

Read more

Poster
N.2
Poster
Non‐invasive tests to predict liver‐related events in a single‐center cohort of 486 HCV cirrhotic patients treated with DAA

E. Degasperi, R. D’Ambrosio, I. Fanetti, R. Perbellini, M.P. Anolli, M. Borghi, R. Soffredini, P. Lampertico Milan

Read more

Poster
N.3
Poster
Incidence of liver‐related events in 647 HCV cirrhotics treated with DAA: a 5‐year single center study

R. D’Ambrosio, E. Degasperi, M.P. Anolli, I. Fanetti, M. Borghi, R. Soffredini, M. Iavarone, G. Tosetti, R. Perbellini, A. Sangiovanni, P. Lampertico – Milan

Read more

Poster
N.4
Poster
Coagulation balance and liver damage in non‐cirrhotic patients with chronic hepatitis C after eradication by Direct‐acting Antiviral Agents (DAAs)

G. Sigon, R. D’Ambrosio, M.G. Clerici, G. Pisano, V. Chantarangkul, R. Sollazzi, A. Cespiati, F. Iuculano, R. Lombardi, F. Peyvandi, P. Lampertico, S. Fargion, A. Tripodi, A.L. Fracanzani – Milan

Read more

Poster
N.5
Poster
New onset steatosis but not persistent steatosis prevents hepatic fibrosis improvement after viral eradication by direct‐acting antiviral therapy (DAAs) in patients with chronic hepatitis C: evaluation by controlled attenuation parameter (CAP) and liver stiffness measurement LSM

A. Cespiati, S. Petta, R. Lombardi, V. Di Marco, V. Calvaruso, C. Bertelli, G. Pisano, E. Fatta, G. Sigon, F. Iuculano, L. Crapanzano, G. Gibilaro, P. Francione, A. Craxì, S. Fargion, A.L. Fracanzani ‐ Milan, Palermo

Read more

Poster
N.6
Poster
The “CASERTA MODEL”: Caserta HCV Free Hospital

V. Messina, A. Petruzziello, E. Tripaldelli, T. Squeglia, A. del Prete, P. Maggi, N. Coppola ‐ Caserta, Naples

Read more

Poster
N.7
Poster
Excellent long‐term virological and clinical response in HDV compensated cirrhotics treated with high dose Bulevirtide beyond 2.5 years: a case series

A. Loglio, P. Ferenci, S.C. Uceda Renteria, H. Holzmann, M. Borghi, R. Perbellini, A. Rimondi, E. Trombetta, S. Giovanelli, L. Porretti, D. Prati, F. Ceriotti, P. Lampertico ‐ Milan, Vienna (Austria)

Read more

Poster
N.8
Poster
A new model of care involving General Practitioners for HCV elimination in patients with mild liver disease: the experience of Pordenone (Friuli Venezia Giulia)

E. Garlatti Costa, G. Marcassa, G. Lucchini, A. Berto, R. De Rosa, M. Tonizzo – Pordenone

Read more

Poster
N.9
Poster
A multimedia multilanguage web‐based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy

L. Frazzoni, U. Sikandar, G. Mazzella, L. Fuccio, F. Bazzoli, S. Brillanti, F. Azzaroli ‐ Bologna, Siena

Read more

Poster
N.10
Poster
Long‐term efficacy and safety of obeticholic acid in patients with PBC from the POISE trial grouped biochemically by risk of disease progression

C. L. Bowlus, M. Trauner, A. Liberman, E. Malecha, L. MacConell, A.E. Kremer, F. Nevens, A. Floreani ‐ Sacramento (CA, USA), Vienna (Austria), San Diego (CA, USA), Erlangen (Germany), Leuven (Belgium), Padua

Read more

Poster
N.11
Poster
Epidemiological and clinical profile of 302 patients with primary biliary cholangitis in Piedmont and Liguria

C. De Benedittis, S. Labanca, A. Picciotto, A. Morgando, E. Vanni, D. Azzolina, M.G. Cittone, M. Pirisi, C. Rigamonti ‐ Novara, Genua, Turin

Read more

Poster
N.12
Poster
Pattern of progression of intrahepatic cholangiocarcinoma impacts on survival: implications for second‐line trials

F. Tovoli, I. Garajovà, M. Iavarone, P. Federico, F. Gelsomino, A. Granito, B. Daniele, A. Forgione, F. Piscaglia ‐ Bologna, Parma, Milan, Naples, Modena

Poster
N.13
Poster
Metabolic reprogramming and mitochondrial dysfunction in HepG2 cells as potential drivers of AIP pathophysiology

M. Longo, M. Meroni, E. Paolini, M.D. Cappellini, I. Motta, A.L. Fracanzani, E. Di Pierro, P. Dongiovanni Milan

Read more

Poster
N.14
Poster
Whole exome sequencing for the diagnosis of rare genetic conditions in patients with unexplained liver disease and complex clinical presentation

S. Pelusi, F. Malvestiti, G. Baselli, C. Bianco, C. Santaniello, L. Santoro, G. Soardo, R. D’Ambrosio, W. Barcellini, M. Miozzo, D. Prati, L. Valenti ‐ Milan, Udine

Read more

Poster
N.15
Poster
EILF‐Italian migrants study: an HCV and HBV micro elimination pilot project

G. Colucci, S. Uceda Renteria, G. Lunghi, F. Ceriotti, E. Sguazzini, S. Spalenza, C. Regazzo, S. Scotti, E. Renesto, A. Zucchetti, C. Paratore, P. Lampertico, M. Colombo ‐ Milan, Geneve (Switzerland)

Read more

Poster
N.16
Poster
Hepatocellular liver injury in hospitalized patients affected by COVID‐19: different factors at different time points

M. Leo, A. Galante, A. Pagnamenta, F.R. Ponziani, A. Gasbarrini, A. De Gottardi – Lugano (Switzerland), Rome, Bellinzona (Switzerland)

Read more

Poster
N.17
Poster
High prevalence of multiple drug resistant bacterial infections in patients with pyogenic liver abscesses following loco regional therapy for liver cancer

F. Colapietro, C. Masetti, N. Pugliese, I. Bianchi, D. Poretti, V. Pedicini, A. Lleo, R. Ceriani, A. Aghemo Rozzano (Milan), Pieve Emanuele (Milan)

Read more

Poster
N.18
Poster
The Fibrosis‐4 index is associated with Intensive Care Unit (ICU) admission in middle‐aged patients with COVID‐19

E. Biliotti, P. Piselli, U. Visco Comandini, R. Lionetti, C. Taibi, L. Vincenzi, S. Al Moghazi, A. Antinori, E. Caraffa, C. Cimaglia, L. Marchioni, A. Mariano, I. Mastrorosa, S. Mosti, A. Navarra, E. Nicastri, F. Palmieri, E. Girardi, G. D’Offizi and ReCOVeRI Study Group – Rome

Read more

Poster
N.19
Poster
High levels of transaminases at admission predict a severe disease course in COVID‐19 hospitalized patients

F. Pelizzaro, M.P. Kitenge, F. Maran, E. Cocconcelli, E. Balestro, P. Spagnolo, A. Cattelan, F. Farinati-Padua

Read more

Poster
N.20
Poster
Pilot screening of HBV and HCV prevalence in at risk populations due to geographical origin and conditions of socio‐economic distress

S. Lorini, L. Gragnani, S. Marri, F. Madia, M. Monti, C. Stasi, L. Petraccia, M. Bamoshmoosh, A.L. Zignego Florence, Sana’a (Yemen)

Read more

Poster
N.21
Poster
Correlation of the transaminases alteration with the clinical severity of patients with COVID‐ 19: a meta‐analysis of the first global outbreak

L. Miele, M. Dajko, G. Marrone, A. De Magistris, M. Biolato, A. Liguori, G.L. Rapaccini, G. Gasbarrini, A. Grieco – Rome

Read more

Poster
N.22
Poster
Eating habits in patients affected by metabolic syndrome and liver disease (hepatitis, cirrhosis and liver transplant)

L. Brodosi, D. Mita, G. Simonetti, G. Vitale, A. Gentile, M. Genovese, G. Marchesini, M.C. Morelli, L. Pironi – Bologna

Read more

Poster
N.23
Poster
Thrombocytopenia in chronic liver disease: the analysis of Italian administrative healthcare data by Fondazione RES

L. Dondi, G. Ronconi, S. Calabria, C. Piccinni, A. Pedrini, I. Esposito, N. Caporaso, U. Vespasiani Gentilucci, A. Iacobellis, N. Martini ‐ Casalecchio di Reno (Bologna), Rome, Naples, San Giovanni Rotondo (Foggia)

Read more

Poster
N.24
Poster
A challenging case of chronic haemolisys in liver cirrhosis: spur cell anemia

M. Bevilacqua, G. Marchi, F. Dima, R. Stupia, V. Paon, D. Ieluzzi, A. Dalbeni, D. Girelli, D. Sacerdoti – Verona

Read more

Poster
N.25
Poster
Psychological profiles and risk of relapse in cirrhosis due to alcohol abuse

A. Galeota Lanza, G. Mazzarone, V.G.M. Moreas, A. Cangiano, F. Giordano, G. Aragiusto, G. Arenga, L. Campanella, A. Ceriello, D. Ferraro, C. Migliaccio, D. Pisaniello, I. Esposito, F. Picciotto, G. Di Costanzo, C. Chierego, C. Esposito, G. Vennarecci – Naples

Read more

Poster
N.26
Poster

NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease
S. Grimaudo, P. Dongiovanni, J. Pihlajamäki, M. Eslam, H. Yki‐Järvinen, R.M. Pipitone, G. Baselli, C. Cammà, V. Di Marco, M. Longo, G. Pennisi, D. Prati, R. Zito, A.L. Fracanzani, A. Craxì, J. George, S. Romeo, L. Valenti#, S. Petta# ‐ Palermo, Milan, Kuopio (Finland), Westmead (NSW, Australia), Helsinki (Finland), Gothenburg (Sweden)

Read more

Poster
N.27
Poster
The role of variant rs17618244 of KLB gene in MAFLD‐related fibrosis

N. Panera, M. Meroni, M. Longo, A. Crudele, L. Valenti, E. Bellacchio, L. Miele, V. D’Oria, E. Paolini, M. Maggioni, A.L. Fracanzani, A. Alisi, P. Dongiovanni ‐ Rome, Milan

Read more

Poster
N.28
Poster
Obeticholic acid demonstrates sustained improvements at month 24 in transaminases and non‐ invasive markers of fibrosis: results of a post hoc analysis from the interim analysis of the REGENERATE study

R. Loomba, V. Ratziu, Q. M. Anstee, S. Harrison, A.J. Sanyal, M. Rinella, Z. Y. Younossi, Z. Goodman, P. Bedossa, R. Shringarpure, H. Zhou, M. Noureddin, E. Bugianesi ‐ San Diego (CA, USA), Paris (France), Newcastle upon Tyne (United Kingdom), San Antonio (TX, USA), Richmond (VA, USA), Chicago (IL, USA), Falls Church (VA, USA), Los Angeles (CA, USA), Turin

Read more

Poster
N.29
Poster
Rare and common ATG7 variants predispose to severe fatty liver disease

G. Baselli, S. Pelusi, E. Ciociola, P. Dongiovanni, M. Maggioni, F. Tavaglione, C. Bianco, R.M. Mancina, L. Santoro, S. Petta, L. Miele, U. Vespasiani Gentilucci, A. Federico, E. Bugianesi, A.L. Fracanzani, H. Reeves, G. Soardo, M. Miozzo, EPIDEMIC study investigators, D. Prati, S. Romeo, L. Valenti ‐ Milan, Gothenburg (Sweden), Rome, Udine, Palermo, Naples, Turin, Newcastle upon Tyne (UK), Catanzaro

Read more

Poster
N.30
Poster
A cholestatic pattern predicts liver outcomes in patients with nonalcoholic fatty liver disease

G. Pennisi, R. M. Pipitone, S. Grimaudo, F. Spatola, V. Di Martino, C. Cammà, V. Di Marco, A. Craxì, S. Petta – Palermo

Read more

Poster
N 31 - 60
N.31
Poster
TM6SF2/PNPLA3/MBOAT7 loss‐of‐function genetic variants impact on NAFLD development and progression both in patients and in in vitro models

M. Longo, M. Meroni, V. Erconi, F. Carli, C. Macchi, D. Ronchi, S. Sabatini, E. Paolini, E.R. De Caro, A. Alisi, L. Miele, G. Soardo, G.P. Comi, L. Valenti, M. Ruscica, A.L. Fracanzani, A. Gastaldelli, P. Dongiovanni ‐ Milan, Pisa, Rome, Trieste

Read more

Poster
N.32
Poster
Increased serum ferritin levels predict long‐term mortality in patients with NAFLD

A. Armandi, R. Younes, G.P. Caviglia, S. Petta, L. Miele, C. Rosso, G. Pennisi, P. Francione, A. Liguori, O. Govaere, A.L. Fracanzani, M. Eslam, L. Valenti, J. George, Q.M. Anstee, E. Bugianesi ‐ Turin, Ingelheim (Germany), Palermo, Rome, Milan, Newcastle upon Tyne (United Kingdom), Westmead (NSW, Australia)

Read more

Poster
N.33
Poster
MicroCT evaluation of low‐density segmented volume in II, IV and VII‐week MCD rats

M. Filibian, L.G. Di Pasqua, C. Berardo, M. Cagna, M. Vairetti, A. Ferrigno – Pavia

Read more

Poster
N.34
Poster
Angiopoietin‐2 associated with NASH in paediatric NAFLD

N. Panera, M. Manco, A. Crudele, M.R. Braghini, M. Bianchi, D. Comparcola, R. De Vito, G. Maggiore, A. Alisi – Rome

Read more

Poster
N.35
Poster
The I148M PNPLA3 variant mitigates Niacin beneficial effects: how the genetic screening in NAFLD patients gains value

E. Paolini, M. Longo, M. Meroni, G. Malaspina, E.R. De Caro, A. Cespiati, R. Lombardi, A.L. Fracanzani, P. Dongiovanni – Milan

Read more

Poster
N.36
Poster
No impact of the 2020 COVID‐19 lockdown on hospitalization rates for alcoholic liver disease in a large tertiary hospital in Milan

C. Masetti, F. Colapietro, N. Pugliese, F. De Fazio, A. Voza, I Bianchi, R. Ceriani, A. Lleo, A. Aghemo ‐ Rozzano (Milan), Pieve Emanuele (Milan)

Read more

Poster
N.37
Poster
General Practitioner databaSe NAFLD (GPS‐NAFLD) study: Italian regional variability of the NAFLD prevalence rate

L. Miele, I. Grattagliano, F. Lapi, M. Dajko, A. Liguori, A. De Magistris, C. Napodano, A. Rossi, G. Rapaccini, A. Gasbarrini, C. Cricelli, A. Grieco – Rome, Florence

Read more

Poster
N.38
Poster
Oleuropein prevents liver damage in NAFL mice by modulating copper‐catalyzed dicarbonyl stress

S.J. Santini, I. Settepanella, C. Balsano ‐ L’Aquila, Rome

Read more

Poster
N.39
Poster
Screening and detecting significant liver fibrosis in patients with NAFLD: a practical approach using non‐invasive tests

G. Alterini, P. Sacco, C. Formichi, C. Ciuoli, E. Ceccarelli, S. Gonnelli, L. Volterrani, M.G. Castagna, F. Dotta, S. Brillanti – Siena

Read more

Poster
N.40
Poster
Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS‐NAFLD) Study

L. Miele, C. Cricelli, F. Lapi, I. Grattagliano, M. Dajko, A. Liguori, A. De Magistris, C. Napodano, G. Marrone, M. Biolato, A. Rossi, G. Rapaccini, A. Grieco, A. Gasbarrini – Rome, Florence

Read more

Poster
N.41
Poster

The PSRC1 rs599839 A>G variant disentangles the risk of coronary artery disease and hepatocellular carcinoma in Italian NAFLD patients
M. Meroni, M. Longo, E. Paolini, E.R. De Caro, A. Alisi, L. Miele, G. Soardo, L. Valenti, A.L. Fracanzani, P. Dongiovanni ‐ Milan, Rome, Trieste

Read more

Poster
N.42
Poster
Prognostic role of platelets‐to lymphocytes ratio (PLR) and neutrophils‐to‐lymphocytes ratio (NLR) in hepatocellular carcinoma patients

F. Pelizzaro, A. Sartori, A. Imondi, B. Penzo, A. Vitale, F. Trevisani, F. Farinati on behalf of the Italian Liver Cancer (ITA.LI.CA) group – Padua, Bologna

Read more

Poster
N.43
Poster
Is first‐ and second‐line immunotherapy sequence the optimal strategy for unresectable hepatocellular carcinoma?

C. Celsa, G. Cabibbo, S. Battaglia, M. Enea, G.E.M. Rizzo, A. Busacca, C. Stornello, P. Giuffrida, A. Craxì, C. Cammà ‐ Palermo

Read more

Poster
N.44
Poster
The protease‐inhibitor serpinB3 as a critical modulator of the stem‐like subset in human cholangiocarcinoma

M. Correnti, A. Cappon, M. Pastore, B. Piombanti, G. Lori, D. VPN Oliveira, P. Munoz‐Garrido, M. Lewinska, J.B. Andersen, C. Coulouarn, L. Sulpice, G. Cavalloni, S. Quarta, A. Biasiolo, M. Fassan, P. Invernizzi, G. Torzilli, F. Marra, P. Pontisso, C. Raggi – Rozzano (Milan), Padua, Florence, Copenhagen (Denmark), Rennes (France), Turin, Monza

Read more

Poster
N.45
Poster
Perfusion analysis with dynamic contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma: a pilot study of a novel parameter aiming to improve the detection of wash‐out

L. Mulazzani, A. Forgione, C. Di Bonaventura, E. Terzi, L. Gramantieri, A. Lyshchik, F. Piscaglia ‐ Bologna, Philadelphia (PA, US)

Read more

Poster
N.46
Poster
Progression‐free survival is a robust surrogate endpoint of overall survival in immunotherapy trials of hepatocellular carcinoma

C. Celsa, G. Cabibbo, M. Enea, S. Battaglia, G.E.M. Rizzo, A. Busacca, D. Matranga, M. Attanasio, M. Reig, A. Craxì, C. Cammà ‐ Palermo, Barcelona (Spain)

Read more

Poster
N.47
Poster
Hepatocellular carcinoma prognostic scores: a 10 years experience

M. Campigotto, M. Giuffrè, A. Colombo, A. Visintin, M. Budel, A. Aversano, C.A.M. Cavalli, A. Piccin, R. Sigon, F. Masutti, C. Abazia, F. Tinè, L.S. Crocè – Trieste

Read more

Poster
N.48
Poster
Abdominal ultrasound and alpha‐foetoprotein for the diagnosis of hepatocellular carcinoma. A diagnostic test accuracy Cochrane review

A. Colli, T. Nadarevic, D. Miletic, V. Giljaca, M. Fraquelli, D. Štimac, G. Casazza ‐ Milan, Rijeka (Croatia), Birmingham (UK)

Read more

Poster
N.49
Poster
A mitochondrial role of RuvBL1 ATPase in the regulation of HCC cell metabolism

I. Simeone, A. Guida, M. Materozzi, S. Polvani, D. Bani, M. Parri, E. Ceni, A. Galli, T. Mello ‐ Florence, Siena

Read more

Poster
N.50
Poster
Fatty Acids regulate the biology of cholangiocarcinoma cells

G. Lori, C. Raggi, B. Piombanti, M. Pastore, R. Booijnk, E. Rovida, J.B. Andersen, M. Lewinska, F. Marra – Florence, Twente (The Netherlands), Copenhagen (Denmark)

Read more

Poster
N.51
Poster
AFP at transplant is associated with a higher risk of HCC recurrence after liver transplantation for patients meeting Milano criteria

B. Magro, D. Pinelli, M. De Giorgio, A. Ghirardi, B. Giuseppe, L. Del Prete, M. Colledan, S. Fagiuoli Bergamo

Read more

Poster
N.52
Poster
Increased platelet aggregation in patients with cirrhosis and hepatocellular carcinoma: a new potential therapeutic target?

A. Zanetto, E. Campello, S. Shalaby, M. Gambato, A. Vitale, U. Cillo, F. Farinati, F.P. Russo, P. Burra, P. Simioni, M. Senzolo – Padua

Read more

Poster
N.53
Poster
Circulating microRNA‐23b‐3p and tissue microRNA‐193a‐3p as promising molecular biomarkers in human hepatocellular carcinoma

I. Grossi, G. Baiocchi, S. Molfino, N. Portolani, M. Ferracin, P. Guerriero, M. Negrini, A. Salvi, G. De Petro Brescia, Bologna, Ferrara

Read more

Poster
N.54
Poster
Copper chelation as a new treatment strategy to counteract hepatocellular carcinoma

S.J. Santini, M.R. Braghini, A. Alisi, C. Balsano ‐ L’Aquila, Rome

Read more

Poster
N.55
Poster
Abnormal glycosphingolipid patterns in human cholangiocarcinoma stem‐like subsets

A. Mannini, C. Raggi, M. Correnti, E. Rovida, M. Aureli, E.V. Carsana, B. Piombanti, M. Pastore, J. Andersen, C. Coulouarn, F. Marra ‐ Milan, Florence, Copenhagen (Denmark), Rennes (France)

Read more

Poster
N.56
Poster
Modeling hepatocellular carcinoma cells dynamics by serological and imaging biomarkers in patients with response to sorafenib and/or regorafenib

P.Colombatto, C.O.Demirtas, G.Ricco, L.Civitano, P.Boraschi, P.Scalise, D.Cavallone, F.Oliveri, V. Romagnoli, P. Bleve, B. Coco, A. Salvati, L. Urbani, F. Bonino, M.R. Brunetto – Pisa, Istanbul (Turkey)

Poster
N.57
Poster
Circulating prostaglandin E2: a novel potential prognostic biomarker in patients with hepatocellular carcinoma

F. Pelizzaro, M. P. Kitenge, R. Cardin, B. Penzo, A. Ponzoni, U. Cillo, A. Vitale, G Businello, G. Munari, M. Fassan, F. Farinati – Padua

Read more

Poster
N.58
Poster
Dynamics of endothelial progenitor cells in patients with advanced hepatocellular carcinoma

C. Campani, M. Capone, F. Liotta, U. Arena, C. Di Bonaventura, S. Colagrande, F. Annunziato, F. Marra Florence

Read more

Poster
N.59
Poster
Comparing surgery versus sorafenib in advanced hepatocellular carcinoma: an Italian weighted study

S. Famularo, M. Donadon, F. Cipriani, F. Giuliante, A. Ferrero, S. Molfino, R. Dalla Valle, M. Chiarelli, M. Maestri, E. Jovine, G.L. Grazi, A. Ruzzenente, R. Memeo, M. Crespi, A. Antonucci, D.P. Bernasconi, F. Romano, G. Griseri, L. Aldrighetti, G. Torzilli, F. Trevisani on behalf of ITA.LI.CA. Group and HE.RC.O.LE.S. Group – Milan, Rozzano (Milan), Rome, Turin, Brescia, Parma, Lecco, Pavia, Bologna, Verona, Bari, Monza, Savona

Read more

Poster
N.60
Poster
OCA administration reduces lung matrix metalloproteinase activation following hepatic ischemia/reperfusion injury in rats

L.G. Di Pasqua, C. Berardo, G. Palladini, M. Cagna, L. Adorini, P. Richelmi, A. Ferrigno, M. Vairetti-Pavia, San Diego (CA, USA)

Read more

Poster
N 61 - 72
N.61
Poster
Treatment of CRKP infections in cirrhotic patients

S. Feldman, S. Di Cola, C. Madge, P. Vassalini, C. Borrazzo, G. Ceccarelli, M. Merli – Rome

Read more

Poster
N.62
Poster
Risk factors for post‐banding ulcer bleeding in cirrhotic patients undergoing elective esophageal varices band ligation

G. Tosetti, E. Farina, R. Caccia, E. Degasperi, M. Primignani, P. Lampertico – Milan

Read more

Poster
N.63
Poster
The impact of a local antibiotic stewardship program: low rate of spontaneous bacterial peritonitis and bacteriascites sustained by multidrug‐resistant organisms

A. Mantovani, M. Bevilacqua, A. Mazzariol, A. Azzini, E. Tacconelli, D. Sacerdoti, A. Dalbeni-Verona

Read more

Poster
N.64
Poster
Analysis of clinical course of portal vein thrombosis in cirrhosis with hepatocellular carcinoma

M. Grasso, A. Vitale, E. Pizzirani, A. Zanetto, E. Gringeri, F. D’Amico, M. Gambato, U. Cillo, P. Burra, M. Senzolo – Padua

Read more

Poster
N.65
Poster
Ultrasound guided paracentesis: a study on reproducibility and diagnostic accuracy of a Pocket‐size Ultrasound Device (PUD)

A. Costantino, S. Costa, D. Noviello, E. Farina, M. Vecchi, P. Lampertico, A. Sangiovanni, M. Fraquelli – Milan

Read more

Poster
N.66
Poster
Liver Transplantation during the COVID‐19 pandemic: a quantitative model balancing individual patient benefit against population healthcare needs

U. Cillo, A.Vitale, M.L. Volk, A.C. Frigo, P. Feltracco, A. Cattelan, G. Brancaccio, G. Feltrin, P. Angeli, P. Burra, S. Lonardi, S. Trapani, M. Cardillo – Padua, Loma Linda (CA, USA), Rome

Poster
N.67
Poster
Proposal of a new evidence based definition of Early Allograft Failure to identify patients who needs early retransplant and call for a prospective external validation study

A.W. Avolio, G. Moschetta, A. Contegiacomo, L. Miele, L. Teofili, G. Spoletini, S. Agnes, F. Frongillo, G. Bianco, G. Marrone, M. Biolato, A. Grieco, A. Gasbarrini, P. Burra ‐ Rome, Padua

Read more

Poster
N.68
Poster
Prevalence and impact on post‐transplant outcome of sarcopenia among patients with cirrhosis on waiting‐list for liver transplantation: preliminary data from an Italian single center experience

F. Invernizzi, M. Iavarone, S. Crespi, B. Antonelli, M. Rusalen, G. Fornoni, G. Carrafiello, G. Rossi, M.F. Donato, P. Lampertico – Milan

Read more

Poster
N.69
Poster
Liver transplant candidates and SARS‐CoV‐2 infection: results from an Italian multicenter cohort

G. Perricone, R. Vigano, C. Mazzarelli, G. Travi, L. Pasulo, F. Invernizzi, M.C. Morelli, D. Patrono, S. Di Sandro, P. De Simone, R. Facchetti, D. Angrisani, S. De Nicola, A. Airoldi, M. Vangeli, L.S. Belli – Milan, Bergamo, Bologna, Turin, Modena, Pisa, Monza

Read more

Poster
N.70
Poster
COVID‐19 and Solid Organ Transplantation (SOT) in Italy: a web‐survey

F. Galiandro, S. Agnes, F. Giovinazzo, A. Vitale, R. Romagnoli, C. Amarelli, U. Maggiore, P. Burra, U. Boggi, A.W. Avolio ‐ Rome, Padua, Turin, Naples, Parma, Pisa

Read more

Poster
N.71
Poster
Liver Transplant in Patient with Breast Cancer Liver Metastasis and Hepatic Failure

V. Giannelli, R. Meniconi, N. Guglielmo, M. Colasanti, C. D’Ambrosio, R. Cianni, E. Cortesi, G.B. Levi Sandri, A.M. Pellicelli, G.M. Ettorre – Rome

Read more

Poster
N.72
Poster
Liver stiffness in the early post‐liver transplant phase as a marker of acute allograft rejection

A. Liguori, M. Pascale, M. Biolato, G. Marrone, L. Miele, R. Gaspari, A.W. Avolio, S. Agnes, A. Grieco – Rome

Read more

Poster

The AISF 2021
Virtual Meetings
A.I.S.F, Italy IT.
22 Feb / 03-04-05 Mar, 2021
Latest News
  • “Wrap-up session” presentata dal Prof. Marco Marzioni 5 Marzo 2021
  • Ultima giornata di lavori 5 Marzo 2021
  • La seconda giornata di lavori del Virtual Annual Meeting AISF 4 Marzo 2021
  • Prima giornata del 53rd Virtual Annual Meeting AISF 4 Marzo 2021
Twitter Highlights
  • Il prossimo 31 Maggio si svolgerà il WEBINAR: “Steatosi epatica non alcolica 2021: linee guida per la pratica clin… https://t.co/c93QRtiCGF
    about 3 hours ago
  • Il prossimo 31 Maggio si svolgerà il WEBINAR: “Steatosi epatica non alcolica 2021: linee guida per la pratica clin… https://t.co/wODsCZSrHN
    about 3 hours ago

Powered By You Pubblicità                         Copyright 2021 @ Associazione Italiana Studio del Fegato